From: Serum microRNA-1233 is a specific biomarker for diagnosing acute pulmonary embolism
 | AUC | 95 % CI | p | Cut-off | Sensitivity (%) | 95 % CI | Specificity (%) | 95 % CI | LR+ | LR− |
---|---|---|---|---|---|---|---|---|---|---|
Acute PE vs. healthy | ||||||||||
miR-27a | 0.79 | 0.65–0.93 | <0.01 | 0.63 | 67 | 50–83 | 92 | 75–100 | 8 | 0.4 |
miR-134 | 0.84 | 0.71–0.96 | <0.001 | 0.51 | 83 | 70–97 | 83 | 58–100 | 5 | 0.2 |
miR-1233 | 0.91 | 0.82–0.99 | <0.001 | 0.53 | 90 | 77–100 | 92 | 75–100 | 10.8 | 0.1 |
miR-27a + miR-134 | 0.88 | 0.78–0.98 | <0.001 | 0.47 | 90 | 77–100 | 83 | 58–100 | 5.4 | 0.1 |
miR-27a + miR-1233 | 0.89 | 0.79–0.99 | <0.001 | 0.48 | 97 | 90–100 | 83 | 58–100 | 5.8 | 0 |
miR-134 + miR-1233 | 0.88 | 0.77–0.98 | <0.001 | 0.40 | 93 | 83–100 | 75 | 50–100 | 3.7 | 0 |
miR-27a + miR-134 + miR-1233 | 0.90 | 0.81–0.99 | <0.001 | 0.50 | 90 | 80–100 | 83 | 58–100 | 5.4 | 0.1 |
Acute PE vs. NSTEMI | ||||||||||
miR-27a | 0.78 | 0.66–0.90 | <0.001 | 0.46 | 63 | 43–80 | 89 | 79–100 | 5.9 | 0.4 |
miR-134 | 0.78 | 0.66–0.90 | <0.001 | 0.74 | 83 | 70–97 | 64 | 46–82 | 2.3 | 0.3 |
miR-1233 | 0.95 | 0.89–1.00 | <0.001 | 0.55 | 90 | 80–100 | 100 | 100–100 | ∞ | 0.1 |
miR-27a + miR-134 | 0.80 | 0.68–0.91 | <0.001 | 0.34 | 87 | 73–97 | 61 | 43–79 | 2.2 | 0.2 |
miR-27a + miR-1233 | 0.96 | 0.91–1.00 | <0.001 | 0.69 | 90 | 77–100 | 100 | 100–100 | ∞ | 0.1 |
miR-134 + miR-1233 | 0.95 | 0.89–1.00 | <0.001 | 0.54 | 90 | 77–100 | 100 | 100–100 | ∞ | 0.1 |
miR-27a + miR-134 + miR-1233 | 0.97 | 0.93–1.00 | <0.001 | 0.71 | 90 | 77–100 | 100 | 100–100 | ∞ | 0.1 |
Acute PE vs. DVT | ||||||||||
miR-27a | 0.83 | 0.67–0.98 | <0.05 | 0.79 | 73 | 57–90 | 100 | 100–100 | ∞ | 0.3 |
miR-134 | 0.84 | 0.72–0.99 | <0.01 | 0.74 | 80 | 67–93 | 100 | 100–100 | ∞ | 0.2 |
miR-1233 | 0.99 | 0.97–1.0 | <0.001 | 0.72 | 97 | 90–100 | 100 | 100–100 | ∞ | 0 |
miR-27a + miR-134 | 0.92 | 0.83–1.0 | <0.001 | 0.63 | 87 | 73–97 | 100 | 100–100 | ∞ | 0.1 |
miR-27a + miR-1233 | 0.99 | 0.97–1.0 | <0.001 | 0.72 | 97 | 90–100 | 100 | 100–100 | ∞ | 0 |
miR-134 + miR-1233 | 0.99 | 0.97–1.0 | <0.001 | 0.72 | 97 | 90–100 | 100 | 90–100 | ∞ | 0 |
miR-27a + miR-134 + miR-1233 | 0.99 | 0.97–1.0 | <0.01 | 0.72 | 97 | 90–100 | 100 | 100–100 | ∞ | 0 |
Acute PE vs. PHT | ||||||||||
miR-27a | 0.66 | 0.50–0.82 | 0.085 | 0.66 | 67 | 50–83 | 80 | 60–100 | 3.3 | 0.4 |
miR-134 | 0.67 | 0.51–0.83 | 0.062 | 0.61 | 70 | 53–87 | 73 | 47–93 | 2.6 | 0.4 |
miR-1233 | 0.91 | 0.83–0.99 | <0.001 | 0.43 | 90 | 80–100 | 93 | 80–100 | 13.5 | 0.1 |
miR-27a + miR-134 | 0.66 | 0.50–0.82 | 0.085 | 0.59 | 70 | 53–87 | 73 | 47–93 | 2.6 | 0.4 |
miR-27a + miR-1233 | 0.92 | 0.84–1.0 | <0.001 | 0.42 | 90 | 77–100 | 93 | 80–100 | 13.5 | 0.1 |
miR-134 + miR-1233 | 0.91 | 0.83–0.99 | <0.001 | 0.42 | 90 | 77–100 | 93 | 80–100 | 13.5 | 0.1 |
miR-27a + miR-134 + miR-1233 | 0.90 | 0.81–0.99 | <0.001 | 0.46 | 90 | 80–100 | 93 | 80–100 | 13.5 | 0.1 |